Peripheral and Central Nervous System Distribution of a CGRP Neutralizing Antibody [125I]-LY2951742 in Male Rats

被引：0
|
作者：
Johnson, Michael [1 ]
Ellis, Bernice [1 ]
Maren, Deanna [1 ]
Morin, S. Michelle [1 ]
Wroblewski, Victor [1 ]
Johnson, Kirk [1 ]
机构：
[1] Lilly Res Labs, Indianapolis, IN USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
I3.002
引用
收藏
页数：2
相关论文
共 28 条
  • [1] PERIPHERAL AND CENTRAL DISTRIBUTION OF THE CGRP NEUTRALIZING ANTIBODY [125I]-LY2951742 IN MALE RATS
    Johnson, K.
    Ellis, B.
    Maren, D.
    Morin, S. M.
    Wroblewski, V.
    Johnson, M.
    CEPHALALGIA, 2016, 36 : 142 - 142
  • [2] Peripheral and Central Distribution of the CGRP Neutralizing Antibody [125I]-LY2951742 in Male Rats
    Johnson, K.
    Johnson, M. P.
    Ellis, B.
    Maren, D. L.
    Morin, S.
    Wroblewski, V. J.
    HEADACHE, 2016, 56 : 67 - 68
  • [3] Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
    Johnson, Kirk W.
    Morin, S. Michelle
    Wroblewski, Victor J.
    Johnson, Michael P.
    CEPHALALGIA, 2019, 39 (10) : 1241 - 1248
  • [4] EVALUATION OF CLINICAL DOSES FOR INHIBITION OF CAPSAICIN-INDUCED DERMAL BLOOD FLOWAND MIGRAINE PREVENTION BY THE CGRP NEUTRALIZING ANTIBODY LY2951742
    Johnson, K.
    Kielbasa, W.
    Zhang, Q.
    Polzer, J.
    Raddad, E.
    Collins, E.
    CEPHALALGIA, 2016, 36 : 23 - 23
  • [5] Analysis of the relationship between efficacious clinical doses for inhibition of capsaicin-induced dermal blood flow and migraine prevention for the CGRP neutralizing antibody LY2951742
    Collins, E. C.
    Zhang, Q.
    Polzer, J.
    Kielbasa, W.
    Raddad, E.
    Johnson, K. W.
    HEADACHE, 2016, 56 : 8 - 8
  • [6] Distribution of mapacalcine receptors in the central nervous system of rat using the [125I]-labeled mapacalcine derivative
    Mourre, C
    Mokrzycki, N
    Neuilly, G
    Richeux, F
    Creppy, EE
    Hughes, M
    BRAIN RESEARCH, 2000, 858 (01) : 136 - 142
  • [7] Induced resistance of the central nervous system to experimental infection with equine encephalomyelitis virus I. Neutralizing antibody in the central nervous system in relation to cerebral resistance
    Morgan, IM
    Schlesinger, RW
    Olitsky, PK
    JOURNAL OF EXPERIMENTAL MEDICINE, 1942, 76 (04): : 357 - 369
  • [8] AUTORADIOGRAPHIC DISTRIBUTION OF I-125 GALANIN BINDING-SITES IN THE RAT CENTRAL-NERVOUS-SYSTEM
    SKOFITSCH, G
    SILLS, MA
    JACOBOWITZ, DM
    PEPTIDES, 1986, 7 (06) : 1029 - 1042
  • [9] HISTO-AUTORADIOGRAPHY OF CENTRAL NERVOUS-SYSTEM IN RATS WITH GENERALIZED TETANUS DUE TO I-125-TOXIN
    ERDMANN, G
    HABERMANN, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 301 (02) : 135 - 138
  • [10] Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats
    T. Uchida
    K. Aoyama
    K. Mori
    T. Usui
    T. Watanabe
    Y. Takariki
    N. Asahara
    M. Hirose
    T. Kimura
    M. Tateishi
    S. Higuchi
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 403 - 410
123